52 results
8-K
EX-99.1
VTRO
Vitro Biopharma, Inc.
22 Jan 24
Vitro Biopharma Announces New Chief Financial Officer
9:17pm
of regenerative medicine and cellular therapies, with ancillary focuses in the research services and cosmeceuticals. With respect to our regenerative
10-12G/A
i1hzu vhjgh1f
21 Dec 22
Registration of securities (amended)
4:50pm
10-12G/A
c7wa1al764iaj
4 Nov 22
Registration of securities (amended)
3:29pm
S-1/A
lsen8u
3 Nov 22
IPO registration (amended)
5:28pm
10-12G
EX-99.1
i0ejq30x6ef4
9 Sep 22
Registration of securities
9:46pm
S-1
uc7yz8g bktok
9 Sep 22
IPO registration
5:13pm
S-1
EX-24
e5xj6ny bk
9 Sep 22
IPO registration
5:13pm
8-K
EX-99.1
c2zs9n7t1w 2v3r6
5 Oct 20
Vitro Biopharma 3rd Quarter ended July 31st 2020 Financial Results of Operations
5:20pm